Add like
Add dislike
Add to saved papers

Adoption of robotic stroke rehabilitation into clinical settings: a qualitative descriptive analysis.

AIM: Through this qualitative research of clinicians' perspectives and experiences, we seek to inform rehabilitation clinicians about the various aspects of adopting and integrating robotic stroke therapy into clinical settings.

METHODS: Semistructured interviews were conducted with individual clinical therapists to seek their perspectives on robotic stroke rehabilitation. From the data collected, qualitative descriptive analysis was used to inductively identify codes, categories and central themes.

RESULTS: The study examined various clinical, human behavioural and organizational factors of adopting robotic rehabilitation into clinical settings, and found that a preimplementation plan addressing various aspects (staff capacity, patient flow and transport, funding mechanism, location and physical space of the robotic devices) needed to be in place to ensure the successful adoption of robotic rehabilitation in a multidiscipline hospital. We also identified how to conduct robotic rehabilitation in terms of the patient inclusion criteria, therapy duration, and patient setup and supervision. We examined the attitudes and views of therapists and patients towards robotic rehabilitation, and presented the benefits that robotic training brought to these two user groups.

CONCLUSION: Both therapist attitude and device benefit work together to shape the motivation of therapists to adopt robotics, and it would be worthwhile to have an adoption plan that actively generated positive attitudes and expounded the benefits of robotic training. Overall, an adoption plan needs to be well thought through and be all-encompassing, and we hope that the findings of this study can assist to inform this plan.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app